The Clinical and Translational Science Awards (CTSA) Program has awarded Stanford School of Medicine $53 million for translational medicine research efforts. A grant renewal, Stanford will continue to collaborate nationally with medical research institutions on sharing resources and improving the process that enables research discoveries to become medical treatment and cures.
The CTSA is overseen by the National Center for Advancing Translational Sciences at the National Institutes of Health.
What does this mean for Stanford?
With the sizable grant renewal, Stanford’s Spectrum program will continue its collaborations with a national network of 50+ academic medical research institutions, known as CTSA Program hubs. A powerful collaborative research network, each academic center acts as a kind of hub for resources, talents, and connections in various geographic markets. Stanford’s position in the heart of Silicon Valley offers the other hubs an incredible opportunity to tap into some of the most innovative regions in the world. Stanford will leverage the funding for the following:
- Educate the next generation of researchers
- Enhance community engagement, including undeserved communities
- Strengthen the School of Medicine’s Research Office
- Develop data science methods, processes, services, and assessment tools to help researchers find ways of improving health outcomes while reducing costs, promoting compliance, and ensuring data accessibility
Stanford Received CTSA Funding in 2008 and 2013
The university previously received CTSA Program grants in 2008 and 2013 with the latter grant totaling $45 million. Stanford has declared the following achievements since winning these grants:
- Launch of the Stanford Predictive and Diagnostics Accelerator
- Data science research portal offering advance tools and data platforms for researchers—including the facilitation of interdisciplinary collaboration
- Establishment of a biobank management system
- Regulatory and compliance programs, including the expansion of a clinical research management system across the institution, a new ClinicalTrials.gov compliance process, and more staff for ensuring improved research quality
- Continued efforts to streamline the process involved with translational research, from first-in-human clinical trials through implementation of preventative measures, treatments, and diagnostics into communities.
About Clinical and Translational Science Award (CTSA)
CTSA is a type of U.S. federal grant administered by the National Center for Advancing Translational Sciences, part of the National Institutes for Health. The CTSA program began in 2006 under the auspices of the National Center for Research Resources, with a consortium of 12 academic health centers. The program was fully implemented in 2012, comprising 60 grantee institutions and their partners.